Literature DB >> 10553903

Re-emergence of HIV after stopping therapy.

T W Chun1, R T Davey, D Engel, H C Lane, A S Fauci.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10553903     DOI： 10.1038/44755

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  204 in total

1.  Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Authors:  T W Chun; J S Justement; S Moir; C W Hallahan; L A Ehler; S Liu; M McLaughlin; M Dybul; J M Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  Cessation of antiretroviral therapy and rapid rebound of HIV.

Authors: 
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

3.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.

Authors:  Viktor Müller; Javier Flavio Vigueras-Gómez; Sebastian Bonhoeffer
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 5.  Surrogacy in antiviral drug development.

Authors:  Sunil Shaunak; Donald S Davies
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

6.  Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.

Authors:  Jana Blazkova; Tae-Wook Chun; Bietel W Belay; Danielle Murray; J Shawn Justement; Emily K Funk; Amy Nelson; Claire W Hallahan; Susan Moir; Paul A Wender; Anthony S Fauci
Journal:  J Infect Dis       Date:  2012-06-25       Impact factor: 5.226

7.  Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.

Authors:  Koen K A Van Rompay; Raman P Singh; Walid Heneine; Jeffrey A Johnson; David C Montefiori; Norbert Bischofberger; Marta L Marthas
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Authors:  Isaure du Chéné; Euguenia Basyuk; Yea-Lih Lin; Robinson Triboulet; Anna Knezevich; Christine Chable-Bessia; Clement Mettling; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Edouard Bertrand; Alessandro Marcello; Stephane Emiliani; Rosemary Kiernan; Monsef Benkirane
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

9.  Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics.

Authors:  Thomas W North; Andradi Villalobos; Selwyn J Hurwitz; Jesse D Deere; Joanne Higgins; Payel Chatterjee; Sijia Tao; Robert C Kauffman; Paul A Luciw; James J Kohler; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection.

Authors:  Yanling Wu; Jing Xue; Chunyu Wang; Wei Li; Lili Wang; Weizao Chen; Ponraj Prabakaran; Desheng Kong; Yujia Jin; Dan Hu; Yulu Wang; Cheng Lei; Diao Yu; Chao Tu; Ariola Bardhi; Igor Sidorov; Liying Ma; Harris Goldstein; Chuan Qin; Lu Lu; Shibo Jiang; Dimiter S Dimitrov; Tianlei Ying
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.